大和:重申长实(1113.HK)“买入”评级 目标价85.2港元
大和资本发表报告表示,经过分析香港地产公司最新业绩的派息情况后,其中长实(1113.HK)表现突出,相信公司未来派息政策将持续增长,加上主要股东李嘉诚增持其股份,认为是时候伺机收集长实,重申其“买入”投资评级,目标价为85.2港元。
大和指,尽管现时香港及其地产市场均面临不确定性,但长实近年来主要策略集中于持续增加其经常性收入。而公司在今年六月时曾提及,在撇除其房地产销售业务,公司全年每股经营现金流为4.8港元。该行估计,长实以250亿港元收购英国酿酒厂后,将可进一步令其每股经营现金流增至5.3港元,并预期公司会持续将早年在中港两地所购入的低成本土地卖出,令公司有充裕的财务资源来支持其派息政策增长。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.